The Novo Nordisk share price is up 51% over the past year, while Eli Lilly is up 84%.

The Novo Nordisk share price is up 51% over the past year, while Eli Lilly is up 84%.
Rate hikes tend to be bad news for ‘jam tomorrow’ sectors but the cycle is ending.
Part of the Mark Allen Group.